Propanc Biopharma annual ebitda
2011
2012
2013
Propanc Biopharma EBITDA Growth & History (PPCB)
Propanc Biopharma's calculated EBITDA was −$1.4M for fiscal 2013.
View full Propanc Biopharma company overviewPropanc Biopharma annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2013 | 2013-06-30 | −$1.4M | $10.2M | — |
| 2012 | 2012-06-30 | −$11.6M | −$9.4M | — |
| 2011 | 2011-06-30 | −$2.2M | — | — |
Propanc Biopharma quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Propanc Biopharma ebitda trends
Across the available reported history, Propanc Biopharma's ebitda increased from −$11.6M to −$1.4M, a change of $10.2M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Propanc Biopharma filings at SEC.gov ↗